SHEILA WILLIAMS: Open Payments
NPI 1710126206 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 26 payments from 13 companies in 2025. Trend: 2023 $379 · 2024 $574 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $139 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| ConvaTec Inc. | 2 | $53 |
| Sandoz Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $31 |
| Janssen Biotech, Inc. | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: SKYRIZI, RINVOQ, Sotyktu, INNOVAMATRIX AC, HYRIMOZ, DUPIXENT, TREMFYA, Rhapsido.
Industry payments across NE — which companies pay providers there.
